EUVIMEDEUVIMED entdecken
Crossref

Recent advances in psychiatric medicines: from rapid-acting antidepressants to precision psychiatry

Harish Babbar, P. S. Kirubhakaran, A. Ronnikka Shiny, Patil Amit Shekhar

BOHR Journal of Pharmaceutical Studies · 2025 · 3 (1) · 14-19

DOI: 10.54646/bjops.2025.14 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BOHR Journal of Pharmaceutical Studies, 2025. Verfasst von Harish Babbar und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychiatric disorders represent a leading cause of global disease burden, with depression, schizophrenia, bipolar disorder, and anxiety disorders contributing substantially to disability-adjusted life years worldwide. Despite decades of pharmacological research, conventional psychiatric medicines, primarily monoaminergic antidepressants and dopamine receptor–based antipsychotics, remain limited by delayed onset of action, incomplete response rates, relapse, and significant adverse effects. Over the past decade, however, psychiatric drug development has entered a transformative phase marked by the emergence of rapid-acting antidepressants, neuroactive steroid modulators, novel receptor targets, psychedelic-assisted therapies, and precision-based approaches. This mini-review critically examines recent advances in psychiatric medicines, focusing on mechanistic innovations, clinical evidence, regulatory milestones, and translational challenges. Key developments include glutamatergic modulators such as ketamine and esketamine, GABAergic neuroactive steroids for postpartum depression, muscarinic and trace amine-associated receptor 1 (TAAR1)-based antipsychotics, the resurgence of psychedelic research, advances in long-acting injectable formulations, and the integration of pharmacogenomics and biomarker-guided therapy. Collectively, these innovations signal a paradigm shift toward faster, more targeted, and individualized psychiatric treatment strategies.

Zitieren

APA

Babbar, H., Kirubhakaran, P. S., Shiny, A. R., & Shekhar, P. A. (2025). Recent advances in psychiatric medicines: from rapid-acting antidepressants to precision psychiatry. BOHR Journal of Pharmaceutical Studies, 3(1), 14-19. https://doi.org/10.54646/bjops.2025.14

Vancouver

Babbar H, Kirubhakaran PS, Shiny AR, Shekhar PA. Recent advances in psychiatric medicines: from rapid-acting antidepressants to precision psychiatry. BOHR Journal of Pharmaceutical Studies. 2025;3(1):14-19. doi:10.54646/bjops.2025.14

BibTeX
@article{Babbar2025,
  author = {Babbar, Harish and Kirubhakaran, P. S. and Shiny, A. Ronnikka and Shekhar, Patil Amit},
  title = {Recent advances in psychiatric medicines: from rapid-acting antidepressants to precision psychiatry},
  journal = {BOHR Journal of Pharmaceutical Studies},
  year = {2025},
  volume = {3},
  number = {1},
  pages = {14--19},
  doi = {10.54646/bjops.2025.14}
}
Kostenlos starten →